跳至主要内容
临床试验/NCT04999722
NCT04999722Unknown不适用

Establishment and Preliminary Evaluation of Digital Three Level Linkage Whole Process Diabetes Management System

Chongqing Renji Hospital, University of Chinese Academy of Sciences0 个研究点目标入组 1,200 人开始时间: 2021年8月25日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,200
主要终点
Change from Baseline Glycated hemoglobin at 12 months

研究概览

简要总结

This study used Nan'an District of Chongqing, China as a pilot project to improve the comprehensive compliance rate of diabetic patients in China, and reduce the physical and economic harm caused by complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of type 2 diabetes.
  • Aged 18-70;
  • HbA1c ≥ 8.0%

排除标准

  • Chronic kidney disease (CKD stage 5);
  • Senile dementia patients;
  • With malignant tumor;
  • Moderate and severe anemia;
  • Severe liver dysfunction;
  • Hemolytic anemia, aplastic anemia, massive blood loss or transfusion, chronic malaria;
  • In the recent one week, large doses of salicylate, erythropoietin, antiretroviral drugs, ribavirin and other drugs that have an impact on the detection of glycosylated hemoglobin were used

结局指标

主要结局

Change from Baseline Glycated hemoglobin at 12 months

时间窗: Month 12

Changes of glycated hemoglobin (percentage)before and after management

次要结局

  • Change from Baseline blood lipid at 12 months(Month 12)
  • Change from Baseline Diabetic nephropathy at 12 months(Month 12)
  • Change from Baseline Blood pressure at 12 months(Month 12)

研究者

发起方
Chongqing Renji Hospital, University of Chinese Academy of Sciences
申办方类型
Other Gov
责任方
Sponsor

相似试验